Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CARBOPLATIN Cause Autoimmune hepatitis? 104 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 104 reports of Autoimmune hepatitis have been filed in association with CARBOPLATIN (Carboplatin). This represents 0.1% of all adverse event reports for CARBOPLATIN.

104
Reports of Autoimmune hepatitis with CARBOPLATIN
0.1%
of all CARBOPLATIN reports
20
Deaths
48
Hospitalizations

How Dangerous Is Autoimmune hepatitis From CARBOPLATIN?

Of the 104 reports, 20 (19.2%) resulted in death, 48 (46.2%) required hospitalization, and 11 (10.6%) were considered life-threatening.

Is Autoimmune hepatitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CARBOPLATIN. However, 104 reports have been filed with the FAERS database.

What Other Side Effects Does CARBOPLATIN Cause?

Off label use (6,100) Neutropenia (5,314) Anaemia (5,312) Febrile neutropenia (4,888) Nausea (4,588) Disease progression (4,538) Thrombocytopenia (4,483) Malignant neoplasm progression (4,177) Diarrhoea (4,154) Dyspnoea (3,494)

What Other Drugs Cause Autoimmune hepatitis?

NIVOLUMAB (481) ATORVASTATIN (357) IPILIMUMAB (352) PEMBROLIZUMAB (315) ADALIMUMAB (237) INFLIXIMAB (191) ATEZOLIZUMAB (146) METHOTREXATE (146) NITROFURANTOIN (130) PREDNISONE (107)

Which CARBOPLATIN Alternatives Have Lower Autoimmune hepatitis Risk?

CARBOPLATIN vs CARBOPROST TROMETHAMINE CARBOPLATIN vs CARBOXYMETHYLCELLULOSE CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN\POLYSORBATE 80 CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\HYPROMELLOSES

Related Pages

CARBOPLATIN Full Profile All Autoimmune hepatitis Reports All Drugs Causing Autoimmune hepatitis CARBOPLATIN Demographics